Human genetics testing firm 23andMe announced Tuesday it will voluntarily delist from the Nasdaq and deregister with the U.S.

(Reuters) -The founder of 23andMe, Anne Wojcicki, has asked a U.S. judge to reopen an auction for the genetic testing company, saying she has the support of a Fortune 500 company with a current market ...

Anne Wojcicki, co-founder of 23andMe, is urging a U.S. judge to reopen the genetic testing companys bankruptcy auction, ...

On May 19, Regeneron Pharmaceuticals (NASDAQ: REGN) announced that it was the successful bidder for substantially all of 23andMe's assets, agreeing to pay $256 million for them. The deal is still ...

Nasdaq previously suspended the trading of 23andMe’s Class A common stock, $0.0001 par value per share (the “Common Stock”), at the opening of business on March 31, 2025 and notified the ...

Me on Tuesday announced it will voluntarily delist from the Nasdaq and de-register with the U.S. Securities and Exchange ...

SAN FRANCISCO, May 27, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading ...